See how ºÚÁÏÃÅ partnered with Bayer, one of the world’s largest life sciences companies, to optimize decision processes in preclinical drug development.
Data mesh
The new foundation for data-driven innovation in healthcare and life sciences
Ìý
In the rapidly evolving world of healthcare and life sciences, organizations are grappling with how to harness vast amounts of data to drive innovation. Traditional data architectures can no longer keep up with the increasing complexity and scale.
Ìý
Experts from ºÚÁÏÃÅ and AWS explore how data mesh is revolutionizing data management and empowering organizations to unlock real-time insights, improve patient outcomes, and accelerate R&D. Discover how adopting a data mesh approach can help your organization scale data-driven innovation with agility, foster collaboration across teams, and transform your data into a powerful asset for future growth.
PRINCE (Preclinical Information Center) represents a major milestone in the digitalizing of our preclinical data domain. We think that it can serve as a blueprint for a future domain-centric decentralized data landscape in R&D.
Empfohlene Inhalte
Hinweis: Dieser Inhalt ist möglicherweise nicht in Ihrer gewünschten Sprache verfügbar.
